CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Executive Vice President acquired 706 shares (option exercise)
- 4 Grant or award Director acquired 14 shares (grant or award)
- 4 Open-market sale Director sold 3,046 shares at $424.91 ($1,294,276)
- 4 Open-market sale Director sold 740 shares at $428.55 ($317,127)
- 4 Gift Director gave 7,400 shares (gift)
- 4 Open-market sale Senior Vice President sold 3,000 shares at $436.00 ($1,308,000)
- 4 Open-market sale President & CEO sold 10,500 shares at an average $434.47 ($4,561,912)
- 4 Open-market sale Senior Vice President sold 13,877 shares at an average $426.70 ($5,921,381)
- 4 Open-market sale President & CEO sold 13,230 shares at an average $382.49 ($5,060,319)
- 4 Grant or award Director acquired 18 shares (grant or award)
- 4 Gift Director gave 455,000 shares (gift)
- 4 Shares withheld for taxes Executive Vice President gave up 6 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP & CFO gave up 90 shares (to pay taxes)
Page 11 of 74 · 1,467 filings